1 / 4

Global Pneumococcal Vaccine Market Size, Industry Trends, Share and Forecast 2020-2026

The pneumococcal vaccine market is expected to show considerable growth at a CAGR of around 4.0% during the forecast period 2020-2026. Major factors for the growth of the market include high spending to curb pneumonia among children in the developed economies.

mansi3210
Download Presentation

Global Pneumococcal Vaccine Market Size, Industry Trends, Share and Forecast 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Global Pneumococcal Vaccine Market, Size, Share, Analysis Report & Forecast to 2025 Request https://www.omrglobal.com/request-sample/pneumococcal-vaccine-market a Free Sample of our Global Pneumococcal Vaccine Market: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The pneumococcal vaccine market is expected to show considerable growth at a CAGR of around 4.0% during the forecast period 2020-2026. Major factors for the growth of the market include high spending to curb pneumonia among children in the developed economies. Moreover, increasing healthcare infrastructure in the emerging economies, rising per capita healthcare expenditure, and growing awareness toward vaccination are also augmenting the market growth. In addition, innovations in the pneumonia vaccines are also providing significant opportunities to the market. A https://www.omrglobal.com/industry-reports/pneumococcal-vaccine-market full Report of Global Pneumococcal Vaccine Market is Available at: As per a report by John Hopkins, around 5.7 million children were died before attaining the age of 5 years in 2016 out of which nearly 25% were due to pneumonia or diarrhea. 15 countries, mainly in Asia and Africa have the most burden of pneumonia. As in 2018, 55% of the global under 5-year age population resides in these countries however they represent 70% of the global under-5 pneumonia and diarrhea deaths. The countries include China, India, Indonesia, Nigeria, Pakistan, the Democratic Republic of the Congo, Ethiopia, Chad, Angola, Somalia, Tanzania, Niger, Bangladesh, Uganda, and Côte d'Ivoire. Growth in the private healthcare expenditure in the emerging economies such as India, China, and Indonesia, and increasing investment by government and international organizations will provide a significant opportunity to the market. Request https://www.omrglobal.com/request-sample/pneumococcal-vaccine-market a Free Sample of our Global Pneumococcal Vaccine Market: GAVI (the Vaccine Alliance), is significantly working toward the children vaccination in the emerging economies. In June 2009, countries including Italy, UK, Canada, Russia, Norway, and Bill & Melinda Gates Foundation have contributed $1.5 billion for Gavi’s vaccination program, Advance Market Commitment (AMC). Due to this, in Gavi supported countries pneumonia vaccination coverage has increased to 48% in 2018 (higher than the global average of 47%), compared to 37% in 2015. By the end of 2018, more than 183 million children have been vaccinated against pneumococcal disease through Gavi. Moreover, two vaccine manufacturers have pledged to provide 1.65 billion doses through 2027. The prices of GAVI’s vaccine dose are also decreasing continuously. During the start of the AMC, the price of the vaccine for the Gavi was $3.5 per dose. After a new agreement with the Serum Institute of India in June 2020, the vaccine will price $2 per dose. Under the agreement, the company will provide 10 million PCV doses every year to Gavi supported countries for the next ten years. Global Pneumococcal VaccineMarket Segmentation By Vaccine Type •Pneumococcal Conjugate Vaccine (PCV13) •Pneumococcal Polysaccharide Vaccine (PPSV23) •Other

  3. By Distribution Channel •Public (Government & Non-Government) •Private By Type •Branded •Generic By Age Group •Children •Adult Regional Analysis •North America •United States •Canada •Europe •UK •Germany •Italy •Spain •France •Rest of Europe •Asia-Pacific •China •India •Japan •Rest of Asia-Pacific •Rest of the World Company Profiles •Astellas Pharma Inc. •China National Biotec Group Company Ltd. •CSL Ltd. •GlaxoSmithKline PLC •Merck & Co., Inc.

  4. •Novavax, Inc. •Pfizer Inc. •Walvax Biotechnology Co., Ltd. •SK Bioscience •Sanofi SA •Serum Institute of India Pvt. Ltd. •PnuVax Incorporated For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/pneumococcal-vaccine-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related